Published in Medical Letter on the CDC and FDA, November 29th, 2009
"Boston Scientific is committed to providing Japanese physicians and their patients the most innovative products and therapies," said David McFaul, Boston Scientific Senior...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.